Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2011 (2011), Article ID 365292, 9 pages
http://dx.doi.org/10.1155/2011/365292
Research Article

Evaluation of Chromosomal Instability in Diabetic Rats Treated with Naringin

1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia
2Department of Pharmacology and Toxicology, College of Pharmacy, Al-Azhar University, Cairo, Egypt

Received 16 May 2011; Accepted 5 July 2011

Academic Editor: Giles E. Hardingham

Copyright © 2011 Saleh A. Bakheet and Sabry M. Attia. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. King, “WHO and the International Diabetes Federation: regional partners,” Bulletin of the World Health Organization, vol. 77, no. 12, p. 954, 1999. View at Google Scholar · View at Scopus
  2. S. F. Clark, “The biochemistry of antioxidants revisited,” Nutrition in Clinical Practice, vol. 17, no. 1, pp. 5–17, 2002. View at Google Scholar · View at Scopus
  3. T. Osawa and Y. Kato, “Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia,” Annals of the New York Academy of Sciences, vol. 1043, pp. 440–445, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. E. Poulsen, “Oxidative DNA modifications,” Experimental and Toxicologic Pathology, vol. 57, supplement 1, pp. 161–169, 2005. View at Google Scholar
  5. S. L. Nuttall, F. Dunne, M. J. Kendall, and U. Martin, “Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus,” Monthly Journal of the Association of Physicians, vol. 92, no. 1, pp. 33–38, 1999. View at Google Scholar · View at Scopus
  6. I. Cousineau, C. Abaji, and A. Belmaaza, “BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis,” Cancer Research, vol. 65, no. 24, pp. 11384–11391, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. Singh, A. Jain, and G. Kaur, “Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage,” Molecular and Cellular Biochemistry, vol. 260, no. 1, pp. 153–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Blasiak, M. Arabski, R. Krupa et al., “DNA damage and repair in type 2 diabetes mellitus,” Mutation Research, vol. 554, no. 1-2, pp. 297–304, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. D. Evans and M. S. Cooke, “Factors contributing to the outcome of oxidative damage to nucleic acids,” BioEssays, vol. 26, no. 5, pp. 533–542, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. L. Powell, J. A. Swenberg, and I. Rusyn, “Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage,” Cancer Letters, vol. 229, no. 1, pp. 1–11, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. P. Lindblad, W. H. Chow, J. Chan et al., “The role of diabetes mellitus in the aetiology of renal cell cancer,” Diabetologia, vol. 42, no. 1, pp. 107–112, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. W. J. Craig, “Health-promoting properties of common herbs,” American Journal of Clinical Nutrition, vol. 70, no. 3, p. 491, 1999. View at Google Scholar · View at Scopus
  13. D. H. Kim, E. A. Jung, I. S. Sohng, J. A. Han, T. H. Kim, and M. J. Han, “Intestinal bacterial metabolism of flavonoids and its relation to some biological activities,” Archives of Pharmacal Research, vol. 21, no. 1, pp. 17–23, 1998. View at Google Scholar · View at Scopus
  14. O. Benavente-García and J. Castillo, “Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity,” Journal of Agricultural and Food Chemistry, vol. 56, no. 15, pp. 6185–6205, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. M. Ali and M. A. El Kedar, “The influence of naringin on the oxidative state of rats with streptozotocin induced acute hyperglycemia,” Zeitschrift für Naturforschung, vol. 59, pp. 726–733, 2004. View at Google Scholar
  16. V. R. Punithavathi, R. Anuthama, and P. S. Prince, “Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats,” Journal of Applied Toxicology, vol. 28, no. 6, pp. 806–813, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. L. Mira, M. T. Fernandez, M. Santos, R. Rocha, M. H. Florêncio, and K. R. Jennings, “Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity,” Free Radical Research, vol. 36, no. 11, pp. 1199–1208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Cavia-Saiz, M. D. Busto, M. C. Pilar-Izquierdo, N. Ortega, M. Perez-Mateos, and P. Muñiz, “Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study,” Journal of the Science of Food and Agriculture, vol. 90, no. 7, pp. 1238–1244, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. W. Baynes and S. R. Thorpe, “The role of oxidative stress in diabetic complications,” Current Opinion in Endocrinology, vol. 3, pp. 277–284, 1997. View at Google Scholar
  20. S. M. Attia, “Deleterious effects of reactive metabolites,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 4, pp. 238–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. N. Ames, “Dietary carcinogens and anticarcinogens, oxygen radicals and degenerative diseases,” Science, vol. 221, no. 4617, pp. 1256–1264, 1983. View at Google Scholar · View at Scopus
  22. M. López-Lázaro, “Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent,” Molecular Nutrition and Food Research, vol. 52, no. 1, pp. S103–S127, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. C. Jagetia and T. K. Reddy, “The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study,” Mutation Research, vol. 519, no. 1-2, pp. 37–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Attia, “Abatement by naringin of lomefloxacin-induced genomic instability in mice,” Mutagenesis, vol. 23, no. 6, pp. 515–521, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. D. N. Vikram, P. Tripathi, and G. B. Jena Ramarao, “Evaluation of streptozotocin genotoxicity in rats from different ages using the micronucleus assay,” Regulatory Toxicology and Pharmacology, vol. 49, pp. 238–244, 2007. View at Google Scholar
  26. S. M. Attia, G. K. Helal, and A. A. Alhaider, “Assessment of genomic instability in normal and diabetic rats treated with metformin,” Chemico-Biological Interactions, vol. 180, no. 2, pp. 296–304, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. G. Davì, A. Falco, and C. Patrono, “Lipid peroxidation in diabetes mellitus,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 256–268, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Ramos-Remus, G. Dorazco-Barragan, F. J. Aceves-Avila et al., “Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients,” Clinical and Experimental Rheumatology, vol. 20, no. 2, pp. 208–212, 2002. View at Google Scholar · View at Scopus
  29. C. M. Batista-González, J. R. Corona-Rivera, B.C. Gómez-Meda, A. L. Zamora-Perez, M. L. Ramos-Ibarra, and G. Zúniga-González, “Micronucleated erythrocytes in preterm newborns in relation to maternal pathology,” Review of Biomedical, vol. 17, pp. 11–16, 2006. View at Google Scholar
  30. S. Sardas, M. Yitmaz, U. Oztak, N. Cakir, and A. Karakaya, “Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation,” Mutation Research, vol. 490, pp. 123–129, 2001. View at Google Scholar
  31. L. M. Martínez-Pérez, R. M. Cerda-Flores, E. C. Gallegos-Cabriales, M. I. Dávila-Rodríguez, E. Ibarra-Costilla, and E. I. Cortés-Gutiérrez, “Frequency of micronuclei in Mexicans with type 2 diabetes mellitus,” Prague Medical Report, vol. 108, no. 3, pp. 248–255, 2007. View at Google Scholar · View at Scopus
  32. S. Bonassi, L. Hagmar, U. Stromberg et al., “Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European study group on cytogenetic biomarkers and health,” Cancer Research, vol. 15, pp. 1619–1625, 2000. View at Google Scholar
  33. S. Amaral, P. J. Oliveira, and J. Ramalho-Santos, “Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species,” Current Diabetes Reviews, vol. 4, no. 1, pp. 46–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Paz and Z. T. Homonnai, “Leydig cell function in streptozotocin-induced diabetic rats,” Experientia, vol. 35, no. 10, pp. 1412–1413, 1979. View at Google Scholar · View at Scopus
  35. W. J. Sexton and J. P. Jarow, “Effect of diabetes mellitus upon male reproductive function,” Urology, vol. 49, no. 4, pp. 508–513, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Tanaka, S. Nakaya, T. Kumai, M. Watanabe, N. Matsumoto, and S. Kobayashi, “Impaired testicular function in rats with diet-induced hypercholesterolemia and/or streptozotocin-induced diabetes mellitus,” Endocrine Research, vol. 27, no. 1-2, pp. 109–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Shrilatha and Muralidhara, “Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences,” Reproductive Toxicology, vol. 23, no. 4, pp. 578–587, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. B. T. Mossman, C. M. Ireland, and M. Filipak, “Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin-secreting cell line (RINr),” Diabetologia, vol. 29, no. 3, pp. 186–191, 1986. View at Google Scholar · View at Scopus
  39. C. C. Pettepher, S. P. LeDoux, V. A. Bohr, and G. L. Wilson, “Repair of alkali-labile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin,” Journal of Biological Chemistry, vol. 266, no. 5, pp. 3113–3117, 1991. View at Google Scholar · View at Scopus
  40. A. Junod, A. E. Lambert, W. Stauffacher, and A. E. Renold, “Diabetogenic action of streptozotocin: relationship of dose of metabolic response,” Journal of Clinical Investigation, vol. 48, no. 11, pp. 2129–2139, 1969. View at Google Scholar · View at Scopus
  41. G. W. Xu, Q. H. Yao, Q. F. Weng, B. L. Su, X. Zhang, and J. H. Xiong, “Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients,” Journal of Pharmaceutical and Biomedical Analysis, vol. 36, no. 1, pp. 101–104, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. W. V. De Castro, S. Mertens-Talcott, A. Rubner, V. Butterweck, and H. Derendorf, “Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies,” Journal of Agricultural and Food Chemistry, vol. 54, no. 1, pp. 249–255, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. R. R. Tice, E. Agurell, D. Anderson et al., “Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing,” Environmental and Molecular Mutagenesis, vol. 35, no. 3, pp. 206–221, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Attia, S. A. Al-Bakheet, and N. M. Al-Rasheed, “Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 6, pp. 404–413, 2010. View at Google Scholar
  45. S. M. Attia, “The genotoxic and cytotoxic effects of nicotine in the mouse bone marrow,” Mutation Research, vol. 632, no. 1-2, pp. 29–36, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. I. D. Adler, “Cytogenetic tests in mammals,” in Mutagenicity Testing—A Practical Approach, S. Venitt and J. M. Parry, Eds., pp. 275–306, IRL Press, Oxford, UK, 1984. View at Google Scholar
  47. A. J. Wyrobek and W. R. Bruce, “Chemical induction of sperm abnormalities in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 11, pp. 4425–4429, 1975. View at Google Scholar · View at Scopus
  48. World Health Organisation, WHO Laboratory Manual for the Examination of Human Semen Samples and Sperm-Cervical Mucus Interaction, Press Syndicate of the University of Cambridge, Cambridge, UK, 3rd edition, 1992.
  49. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  50. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 214–226, 1959. View at Google Scholar · View at Scopus
  51. M. E. Anderson, “Determination of glutathione and glutathione disulfide in biological samples,” in Methods Enzymology, A. Meister, Ed., pp. 548–555, Academic Press, New York, NY, USA, 1985. View at Google Scholar
  52. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  53. S. A. Bakheet, S. M. Attia, N. M. Al-Rasheed et al., “Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells,” Mutagenesis, vol. 26, no. 4, pp. 533–543, 2011. View at Google Scholar